Xiaoyan Yu

Bcl‐2 phosphorylation confers resistance on chronic lymphocytic leukaemia cells to the BH3 mimetics ABT‐737, ABT‐263 and ABT‐199 by impeding direct binding

Zhichao Zhang, T. Song, Yubo Liu, 2016, British journal of pharmacology.

Systems analysis of phosphorylation‐regulated Bcl‐2 interactions establishes a model to reconcile the controversy over the significance of Bcl‐2 phosphorylation

Zhichao Zhang, T. Song, Anhui Wang, 2018, British journal of pharmacology.

Novel Mcl‐1/Bcl‐2 Dual Inhibitors Created by the Structure‐Based Hybridization of Drug‐Divided Building Blocks and a Fragment Deconstructed from a Known Two‐Face BH3 Mimetic

Zhichao Zhang, T. Song, Xiangqian Li, 2015, Archiv der Pharmazie.

Discovery of a Small‐Molecule pBcl‐2 Inhibitor that Overcomes pBcl‐2‐Mediated Resistance to Apoptosis

Zhichao Zhang, T. Song, Xiangqian Li, 2015, Chembiochem : a European journal of chemical biology.

A novel BH3 mimetic efficiently induces apoptosis in melanoma cells through direct binding to anti‐apoptotic Bcl‐2 family proteins, including phosphorylated Mcl‐1

Zhichao Zhang, T. Song, Yubo Liu, 2015, Pigment cell & melanoma research.

Mechanism of synergy of BH3 mimetics and paclitaxel in chronic myeloid leukemia cells: Mcl-1 inhibition.

Zhichao Zhang, T. Song, Yubo Liu, 2015, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.